Public Comments
Comments provided on: June 29, 2020
Comments provided to: Food and Drug Administration (FDA)

Goals:
🎥 Watch the webinar recording:
TIME | PROPOSED AGENDA | PROPOSED SPEAKERS |
8:30-8:45 | Welcome Opening remarks (MRCT Center) | Richardae Araojo Sylva Collins Barbara Bierer |
8:45-9:10 | Keynote speaker: A clinical trialist’s perspective “System Redesign needed to make sense of findings that suggest heterogeneity of treatment effect” | Robert Califf |
9:10-10:15 | Challenges for the Regulator, Clinician, and Patient: Population safety and efficacy but individual treatment Moderator: David Strauss | Christopher Granger Ellis Unger Janet Wittes Donna Cryer Danielle Campbell Aloka Chakravarty |
10:15-10:30 | Break | |
10:30-11:00 | Goals of subgroup analyses, assessing standards for analysis of differences, and limits of interpretation | Steven Snapinn |
11:00-11:30 | Subgroup identification: Utility, impact, and methods | Scott Evans |
11:30-12:45 | Statistical Methods I Moderator: Li Chen | Stuart Pocock Stephen Ruberg Lisa Lavange Mark Rothmann Kathleen Fritsch Ravi Varadhan |
12:45-12:50 | Closing remarks | Richardae Araojo and Barbara Bierer |
Time | Proposed Agenda | Proposed Speakers |
8:30-9:30 | Statistical Methods II Moderator : Steve Snapinn | Donald Berry Thomas Louis Gene Pennello Frank Bretz |
9:30- 10:00 | Summary Discussion of Statistical Methods I and II | |
10:00-10:15 | Break | |
10:15-11:15 | Data Visualization and the role of graphical representation Moderator: Marcia Levenstein | Frank Harrell Ilya Lipkovich Michael Griswold |
11:15-12:15 | Panel: Statistical methodologies, pros and cons Moderator: Thomas Gwise | Frank Rockhold Qi Jiang Thomas Gwise John Scott |
12:15-12:45 | Open discussion and Conclusions | FDA and MRCT Center |
12:45- 1:00 | Core team to discuss Day 1 & Day 2 wrap up | Planning committee |
Dr. Barbara Bierer, MRCT Center Faculty Director, will be speaking on “Improving the Performance of Clinical Trial for Global Directives” at the Global Clinical Research Summit in Seoul on September 7th. Learn more
Description: We are delighted to announce a collaboration with Clinical Data Interchange Standards Consortium (CDISC) on the MRCT Center Clinical Research Glossary. This marks an important first step in making plain language a global clinical research standard. The MRCT Center Clinical Research Glossary was piloted in 2020 to test the process of creating a plain language glossary of commonly used clinical research terms that is freely available to everyone.
Please join us on April 5 from 11 AM – 12 PM ET for a joint webinar with the MRCT Center and CDISC. Learn about MRCT Center’s robust process of developing the plain language glossary, the CDISC public review, and how this collaboration will empower patients and participants with the necessary tools and information to make informed research decisions.
Click here to register.
Published on: April 18, 2023
Published in: CellPress Med
Free access until June 7, 2023
Description: Drs. Barbara Bierer, Luke Gelinas, Nora Hutchinson, and Deborah Zarin deployed a modified Delphi process to establish consensus on 35 recommendations across five domains related to the role of scientific review and landscape analysis in preventing uninformative trials. Their article, “How to limit uninformative trials: Results from a Delphi working group,” was recently published in Med.
Presented on: March 27, 2023
Description: This case study describes how an IRB navigated returning results of a new COVID-19 assay from a non-CLIA-certified lab during a public health emergency.
Related Resources:
Link to IRR Roadmap by Role.
Date: April 5, 2023
A discussion about the MRCT Center’s collaboration with CDISC to promote the MRCT Center’s Clinical Research Glossary, a freely available plain language glossary of commonly used clinical research terms developed with and for patients and their caregivers, as a global research standard.
Learn about the MRCT Center’s robust process of developing the plain language glossary, the CDISC public review process, and how this collaboration will empower patients and participants with the necessary tools and information to make informed research decisions.
Related Resources:
Presentation Slides
Audience Q&A
Speaker Bios
Link to Public Review Website
Helpful Video Tutorial about how to submit a Public Comment
Link to a Public Review Outreach Template
Date: May 4th, 2023
Description: Learn about the Accessibility by Design (AbD) in Clinical Research Toolkit, developed by the MRCT Center in collaboration with people with disabilities, caregivers, allies, disability rights advocates, and stakeholders working in clinical research.
We present the background, structure, and key themes of the AbD Toolkit. Invited speakers then discuss their experiences as participants, caregivers, and leaders in clinical research and how the AbD Toolkit may be utilized to facilitate change.
Related Resources:
Accessibility by Design (AbD) Toolkit
Integrating Supported Decision-Making into the Clinical Research Process (Publication)
MRCT Center Diversity, Inclusion, and Equity in Clinical Research Guidance Document and Toolkit
Equity by Design in Clinical Research: The EbD Metrics Framework (FRAMEWORK)
Released on: November 2019
Developed by: MRCT Center Post-Trial Responsibilities Workgroup